Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The European Respiratory Journal
|
July 1, 1993
Environmental pleural plaques in an asbestos exposed population of northeast Corsica
F Rey, C Boutin, J Steinbauer, et al.
Environmental Health Perspectives
|
October 1, 1994
Environmental asbestotic pleural plaques in northeast Corsica: correlations with airborne and pleural mineralogic analysis
F Rey, C Boutin, J R Viallat, et al.
British Journal of Cancer
|
October 31, 2008
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
V Catalano, F Graziano, D Santini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer
S Cascinu, R Labianca, P Alessandroni, et al.
Cancer Investigation
|
June 2, 2000
Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer
S Cascinu, M Ligi, E Del Ferro, et al.
British Journal of Cancer
|
March 5, 2009
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
V Catalano, F Loupakis, F Graziano, et al.
British Journal of Cancer
|
August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, et al.
The Pharmacogenomics Journal
|
December 24, 2008
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
F Graziano, A Ruzzo, E Canestrari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2011
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer
V Catalano, F Loupakis, F Graziano, et al.
The Pharmacogenomics Journal
|
June 6, 2007
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
A Ruzzo, F Graziano, F Loupakis, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The European Respiratory Journal
|
July 1, 1993
Environmental pleural plaques in an asbestos exposed population of northeast Corsica
F Rey, C Boutin, J Steinbauer, et al.
Environmental Health Perspectives
|
October 1, 1994
Environmental asbestotic pleural plaques in northeast Corsica: correlations with airborne and pleural mineralogic analysis
F Rey, C Boutin, J R Viallat, et al.
British Journal of Cancer
|
October 31, 2008
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
V Catalano, F Graziano, D Santini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer
S Cascinu, R Labianca, P Alessandroni, et al.
Cancer Investigation
|
June 2, 2000
Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer
S Cascinu, M Ligi, E Del Ferro, et al.
British Journal of Cancer
|
March 5, 2009
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
V Catalano, F Loupakis, F Graziano, et al.
British Journal of Cancer
|
August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, et al.
The Pharmacogenomics Journal
|
December 24, 2008
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
F Graziano, A Ruzzo, E Canestrari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2011
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer
V Catalano, F Loupakis, F Graziano, et al.
The Pharmacogenomics Journal
|
June 6, 2007
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
A Ruzzo, F Graziano, F Loupakis, et al.
Page
of 3